Tivo Renews Intellectual Property License with Foxtel

Tivo Renews Intellectual Property License with Foxtel

TiVo, a provider of entertainment technology, said pre-market Monday that Foxtel, an Australian pay-TV platform, has signed a multi-year intellectual property (IP) license renewal. This agreement offers Foxtel ongoing access to TiVo’s industry-leading entertainment discovery patent portfolios. “Our relationship with Foxtel demonstrates how pay-TV providers around the world use TiVo’s intellectual property to reach consumers in more innovative ways,” said Samir Armaly, a TiVo unit executive said in a statement. […]

Read More ˃
International Speedway Misses Projections On Q2 EPS And Revenues

International Speedway Misses Projections On Q2 EPS And Revenues

International Speedway reported fiscal Q2 adjusted EPS of $0.30, up from $0.29 in the same period a year ago and missing the estimate of $0.32 from analysts polled by CapIQ. For the quarter ended May 31 total revenues of $165.3 million were down from $167.6 million in the same period a year ago and fell short of the Street projection of $166.8 million. The company reiterated full year guidance and […]

Read More ˃
New York Community Bancorp Sells Mortgage Banking Business

New York Community Bancorp Sells Mortgage Banking Business

New York Community Bancorp said pre-market Tuesday it has entered into an agreement to sell its mortgage banking business, which was acquired as part of its 2009 FDIC-assisted acquisition of AmTrust Bank, to residential mortgage provider, Freedom Mortgage. Freedom will acquire both New York Community’s origination and servicing platforms, as well as its mortgage servicing rights portfolio with a current aggregate unpaid principal balance of $21.0 billion. It is expected […]

Read More ˃
Zimmer Biomet Holdings Price Target Raised by RBC

Zimmer Biomet Holdings Price Target Raised by RBC

Zimmer Biomet Holdings received a price-target increase Wednesday from RBC Capital Markets, a week after the maker of orthopedic reconstructive products said it received from the Food & Drug Administration a successful clearance of a warning letter related to its Zhejiang, China manufacturing facility. The new price target from RBC is $140 per share, up from $133. The stock closed Tuesday at $127.22, up 1.8% from where it closed before […]

Read More ˃
Baxter Enters into Drug Development Collaboration

Baxter Enters into Drug Development Collaboration

Baxter International, a provider of renal and hospital products, said early Wednesday that it has entered into an agreement with India-based Dorizoe Lifesciences Limited that will facilitate the accelerated development of more than 20 generic injectable products. Under the deal, Dorizoe will work with Baxter to perform certain product development activities, while Baxter will hold worldwide manufacturing and commercialization rights for the products. The deal covers anti-infectives, oncolytics, and cardiovascular […]

Read More ˃